Clinical Trials Browser

Completed × Anatomic Stage II Breast Cancer AJCC v8 × Clear all

NCT03620201 2024-10-22

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer

Phase 1 Completed

Anatomic Stage II Breast Cancer AJCC v8

NCT03132467 2024-06-05

Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer

Phase EARLY_PHASE1 Completed

16 enrolled 8 charts

Anatomic Stage II Breast Cancer AJCC v8